doi: 10.1007/s002770000281.
Antiangiogenesis in hematologic diseases
- PMID: 11401095
- DOI: 10.1007/s002770000281
Item in Clipboard
Antiangiogenesis in hematologic diseases
Ann Hematol.
2001 Apr.
No abstract available
Similar articles
-
[Myelofibrosis and lesions of the bone marrow circulation].Union Med Can. 1976 Nov;105(11):1650-60. Union Med Can. 1976. PMID: 982684 French. No abstract available.
-
[Study on bone marrow microvascular density in hematological diseases].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Dec;12(6):852-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15631677 Chinese.
-
A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies.J Hematother Stem Cell Res. 2002 Feb;11(1):33-47. doi: 10.1089/152581602753448522. J Hematother Stem Cell Res. 2002. PMID: 11847002 Review.
-
American Society of Hematology - 45th annual meeting and exposition.IDrugs. 2004 Feb;7(2):128-32. IDrugs. 2004. PMID: 15057655 No abstract available.
-
[Thalidomide in oncological and hematological diseases].Duodecim. 2010;126(12):1413-9. Duodecim. 2010. PMID: 20617746 Review. Finnish.
Cited by
-
Endothelial hyperplasia: an important indicator of actual angiogenesis.Br J Cancer. 2002 Feb 12;86(4):658. doi: 10.1038/sj.bjc.6600055. Br J Cancer. 2002. PMID: 11870552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical